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The thyroid hormone (TH) regulates 
many physiological functions in 
vertebrates including the cardiovascular 
system, metabolism, brain development, 
and growth. This can lead to serious 
physiological complications for patients 
suffering from a thyroid disorder. 
According to the American Thyroid 
Association as many as 20 million 
Americans suffer from thyroid diseases 
and 60% are unaware of  their condition. 
Many people are misdiagnosed or 
symptoms go unrecognized because 
thyroid hormone biology is complicated 
and not completely understood. 
Consequently, the treatments for thyroid 
disorders are limited. The most common 
treatment is Synthroid, a synthetic thyroid 
hormone, which is taken orally and is 
one of  the most commonly prescribed 
medications in the United States. 
The thyroid hormone is regulated by a 
cascade of  hormone releases initiated 
by the hypothalamus, mediating the 
pituitary gland, and terminating in the 
stimulation of  the thyroid gland. The 
activated thyroid gland releases TH into 
the blood stream. A negative feedback 
mechanism also exists, which terminates 
the signal from the hypothalamus if  the 
concentration of  TH gets too high. The 
hormones released from the thyroid 
gland are primarily T4, the inactive 
form of  TH. T4 attaches to carrier 
proteins in the blood and it travels to its 
target cells. Upon reaching the target 
cell, T4 becomes activated through the 
action of  a deiodinase to become T3. 
After activation, T3 activates its nuclear 
receptor leading to gene regulation 
and causes an increase in physiological 
functions. This is a slow process and can 
take hours or even days to see an effect. 
The biological processes that increase 
include metabolic rate, cardiac output, 
and body temperature among others. 
Recent research has shown that T1AM, 
a compound found in various tissues 
throughout the body, may play a role 
in thyroid hormone regulation. T1AM 
acts on the Trace Amine Associated 
Receptor (TAAR). TAAR activation leads 
to physiological effects in opposition to 
those induced by TH. This led to the 
proposal of  a new homeostatic model 
for thyroid hormone regulation. It was 
traditionally thought that a person with 
hypothyroidism was suffering from too 
little T3, but the model suggests that they 
may have too much T1AM. And for a 
person with hyperthyroidism it is not that 
they have too much T3, but that they may 
have too little T1AM.
The goal of  this project is to develop 
novel T1AM derivatives to better 
understand the role of  TAAR and 
T1AM in TH biology. Specifically, these 
compounds will incorporate an extra 
phenyl ring, and based on previous 
work, may be antagonists for TAAR. 
To this end, a synthesis of  our novel 
phenyl substituted T1AM derivative 
was commenced with a commercially 
available compound. Thus far, the 
starting material has undergone two 
transformations: a boc protection and 
iodination. We have successfully separated 
the mono-boc protected amine and the 
mono-iodonated product from the  
di-products. The next step in the synthesis 
is the Suzuki coupling, which is currently 
being examined. Selective regulators for 
TAAR will be valuable biological tools 
that may lead to new treatments for 
thyroid disorders.
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